Risk of Major Bleeding With Potent Antiplatelet Agents After an Acute Coronary Event: A Comparison of Ticagrelor and Clopidogrel in 5116 Consecutive Patients in Clinical Practice

BACKGROUND: Major bleeding after acute coronary syndrome predicts a poor outcome but is challenging to define. The choice of antiplatelet influences bleeding risk. METHODS AND RESULTS: Major bleeding, subsequent myocardial infarction (MI), and all‐cause mortality to 1 year were compared in consecuti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Heart Assoc
Main Authors: Mullen, Liam, Meah, Mohammed N., Elamin, Ahmed, Aggarwal, Suneil, Shahzad, Adeel, Shaw, Matthew, Hasara, Jaroslav, Rashid, Muhammad, Fisher, Michael, Ali, Turab, Patel, Billal, Ding, Wern Y., Grainger, Ruth, Heseltine, Thomas, Kirmani, Bilal H., Obeidat, Mohammed, Kasolo, Yande, Thatchil, Jecko, Khand, Aleem
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8174168/
https://ncbi.nlm.nih.gov/pubmed/33834845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.120.019467
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados